Comparative proteomics study of freshly isolated, in vitro cultured, and proliferating islet preparation cells

BACKGROUND

In vitro islet expansion has recently drawn interest for its potential application in diabetes therapy, while how islet cells adapt to in vitro circumstances is not quite clear.

AIM

Proteomics changes of cultivated islet cells under different conditions were examined in this study.

MATERIAL/SUBJECTS AND METHODS

A comparative proteomics study was performed on fresh isolated islet cells, cultured cells and in vitro proliferating islet cells stimulated by basic fibroblast growth factor via electrophoresis and liquid chromatography in tandem with mass spectrometry.

RESULTS

In total, 1897 proteins were identified in this study. Hierarchical analysis revealed substantial changes in the proteome during cultivation but relatively less difference between different culture conditions. Over 100 proteins showed significantly different expression levels between groups, most of which are involved in metabolism or cell process pathways. Overall, the detected proteins were involved in 152 known pathways. Furthermore, in-depth investigation suggested that some proteins, such as extracellular signal-regulated protein kinases and Rac, might play key roles in the proliferation, apoptosis, and differentiation of in vitro cultured islet cells.

CONCLUSION

We established comparative proteome references of fresh and cultured islet cells, which could provide useful information for future islet transplantation strategy.

Peak BMD assessment in a Chinese infantry recruit group

Peak bone mass is an important factor influencing the occurrence of osteoporosis and osteoporotic fracture in adulthood. We measured the areal bone mineral density (BMD) in a Chinese male infantry recruit group ranging in age from 17 to 23 years and subsequently assessed peak BMD at the lumbar vertebrae and hip. This study included 812 Chinese men of Han ethnicity from 11 provinces and municipalities of China. The BMD, bone mineral content and the bone area of the lumbar vertebrae (L1-4), left femoral neck and total hip were measured using dual-energy X-ray absorptiometry. Height, weight, waist and hip circumference were also measured at the same time. BMD at the lumbar vertebrae, femoral neck and total hip reached a plateau at 22 years of age. The peak value of BMD at these 3 sites was 1.209±0.175, 1.098±0.177 and 1.122±0.151 (g/cm2), respectively. Stepwise regression analysis showed that age and weight most contributed to the variance in BMD (P<0.001). The average age when reaching peak BMD in this study is earlier than the ages reported in previous studies, and the value of peak BMD is higher than that reported previously in Chinese males. This study provides the newest peak BMD data on Chinese men.

Tumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA delivery

Delivering small interfering RNA (siRNA) to tumors using clinically viable formulations remains the primary technical hurdle that prevents the development of siRNA therapy for cancer treatment. Over the past several years, significant effort has been devoted to explore novel delivery strategies, whereas relatively little attention has been paid to understand the impact of physiological constrains such as tumor vasculature on the efficiency of siRNA delivery. Using the previously described positive-readout tumor models where successful siRNA delivery leads to an upregulation of β-galactosidase within tumor sections, we analyzed the spatial distribution of localized target knockdown within tumor sections relative to tumor hypoxia and found that stable nucleic acid lipid particle (SNALP), a lipid nanoparticle-based delivery system, predominantly delivers siRNA to areas adjacent to functional tumor blood vessels. Increasing tumor vascularity by ectopic expression of VEGF resulted in more efficient siRNA delivery to tumors using SNALP. SNALP-mediated delivery of a siRNA-targeting Ran GTPase led to target knockdown and significant antitumor efficacy in the highly vascularized HepG2-derived liver tumors, but not in the poorly vascularized HCT-116-derived liver tumors. These results highlight the significant impact of tumor vasculature on siRNA delivery and call for a more focused effort on addressing tumor penetration after extravasation, an area of only limited attention currently.

Secondary metabolites of Pyrenochaeta sp. B36, an endophytic fungus from Annona squamosa L

Four new metabolites, named pyrenochaetamide A, pyrenochaetolide A, pyrenochaetoxy A and pyrenochaetolide B, together with five known compounds, were isolated from strain Pyrenochaeta sp. B36, an endophytic fungus of Annona squamosa L. Their structures were elucidated by spectroscopic analyses including 1D- and 2D-NMR (HMQC, HMBC, ¹H-¹H COSY and NOESY) and HRFT-MS. The cytotoxic activities of these compounds were evaluated and some of them showed substantial effect.

FRS2α is essential for the fibroblast growth factor to regulate the mTOR pathway and autophagy in mouse embryonic fibroblasts

Although the fibroblast growth factor (FGF) signaling axis plays important roles in cell survival, proliferation, and differentiation, the molecular mechanism underlying how the FGF elicits these diverse regulatory signals is not well understood. By using the Frs2α null mouse embryonic fibroblast (MEF) in conjunction with inhibitors to multiple signaling pathways, here we report that the FGF signaling axis activates mTOR via the FGF receptor substrate 2α (FRS2α)-mediated PI3K/Akt pathway, and suppresses autophagy activity in MEFs. In addition, the PI3K/Akt pathway regulated mTOR is crucial for the FGF signaling axis to suppress autophagy in MEFs. Since autophagy has been proposed to play important roles in cell survival, proliferation, and differentiation, the findings suggest a novel mechanism for the FGF signaling axis to transmit regulatory signals to downstream effectors.

Expression of smoothened in mouse embryonic maxillofacial development

Hedgehog (Hh) signaling plays many key roles in the development of Drosophila and vertebrate embryos including regulation of craniofacial development. The seven-transmembrane protein, smoothened (Smo) transduces the Hh signal across the plasma membrane as an essential receptor of PTCHED1/2. There are few studies that evaluate the detailed expression of Smo in mouse embryonic craniofacial development. We investigated the expression patterns of Smo during murine embryonic craniofacial development using in situ hybridization (ISH), studies of whole-mounts and sections, immunohistochemistry, quantitative real time PCR, and Western blot analysis. We found that Smo mRNA was expressed in the face of mouse embryos at 11 and 12.5 days post coitum (dpc). After 13.5 dpc, the expression decreased to a low level and was faintly detected after birth. Smo protein could be detected also in embryos at 11, 12.5, and 14.5 dpc. After 15.5 dpc, the expression was very faint and paralleled the gene expression studies. No expression was detected in whisker follicle during facial development and faint signal was detected in Meckel's cartilage. These findings concerning Smo expression should guide further investigation of sonic Hh signaling pathway gene function during maxillofacial development.

Cytotoxic effects of MgO nanoparticles on human umbilical vein endothelial cells in vitro

The MgO nanoparticles are widely used in many fields. However, the toxicity of these nanoparticles to cells and organs remains fairly undiscovered. In this study, the cytotoxicity of MgO nanoparticles on human umbilical vein endothelial cells (HUVECs) in vitro was examined. The morphology and size of MgO nanoparticles were analysed by the transmission electron microscope (TEM) and nanoparticle size analyser. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2 h-tetrazolium bromide) assay, 4',6-diamidino-2-phenylindole (DAPI) staining analysis, NO release and total antioxidation competence (T-AOC) assay were used to evaluate the cytotoxicity of MgO nanoparticles. The results showed that most MgO nanoparticles were spherical with agglomerated state and the diameter of single particle was about 100 nm. Meanwhile, low concentration (below 200 [micro sign]g/ml) of MgO nanoparticles suspension showed no cytotoxicity by MTT assay. However, once the concentration of MgO nanoparticles was higher than 500 [micro sign]g/ml, the relative growth rate was lower than the control. The DAPI staining analysis results showed no significant difference of the cells morphology between the groups with or without MgO nanoparticles. In addition, the MgO nanoparticles significantly enhanced the NO release and T-AOC content of the HUVECs. The testing results indicated that low concentration of MgO nanoparticles exhibited non-cytotoxicity.

A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia

Novel agents are needed for patients with refractory and relapsed acute lymphoblastic leukaemia (ALL). Combotox is a 1:1 mixture of two immunotoxins (ITs), prepared by coupling deglycosylated ricin A chain (dgRTA) to monoclonal antibodies directed against CD22 (RFB4-dgRTA) and CD19 (HD37-dgRTA). Pre-clinical data demonstrated that Combotox was effective in killing both pre-B-ALL cell lines and cells from patients with pre-B ALL. A clinical study of paediatric patients in which 3 of 17 patients with ALL experienced complete remission, supported the preclinical work and motivated this study. This study was a Phase I, dose-escalation trial using Combotox in adults with refractory or relapsed B-lineage-ALL. A cycle consisted of three doses, with one dose given every other day. Dose levels were 3, 5, 6, 7 and 8 mg/m(2) per dose. Seventeen patients, aged 19-72 years, were enrolled in this multi-institution study. The maximum tolerated dose was 7 mg/m(2) /dose (21 mg/m(2) /cycle) and vascular leak syndrome was the dose-limiting toxicity. Two patients developed reversible grade 3 elevations in liver function tests. One patient achieved partial remission and proceeded to allogeneic stem cell transplantation. All patients with peripheral blasts experienced decreased blast counts following the administration of Combotox. Thus, Combotox can be safely administered to adults with refractory leukaemia.

Laminar shear stress promotes endothelial cell migration and inhibits cell apoptosis in the presence of hydroxyurea

Cell migration plays important roles in both physiological and pathological processes. Recent studies have shown that hydroxyurea, which is an anti-proliferative inhibitor, can affect cell morphology and specific gene expression of endothelial cells (ECs). In vivo, the functions of ECs are modulated by shear stress. It is well known that shear stress can have effects on EC migration by affecting cell morphology, cytoskeletal arrangement and cell-cell junction, and activating mechanosensors, inducing the changes of signaling pathways, and then increasing or decreasing the expression of gene and protein. However, the influences of hydroxyurea on EC function under shear stress are still unclear. In present study, we investigated the effects of hydroxyurea on EC proliferation, apoptosis and migration under laminar shear stress. The results showed that hydroxyurea prevented growth of ECs in a dose-dependent manner. Hydroxyurea at 2 mM completely inhibited the proliferation of ECs. The results also demonstrated that hydroxyurea induced EC apoptosis, but it was inhibited by 15.27 dyn/cm2 laminar shear stress. Furthermore, shear stress induced cell migration in the presence of hydroxyurea. Therefore, 2 mM hydroxyurea, which completely inhibited the proliferation of HUVECs, could be used to eliminate any confounding effect of shear stress on proliferation in shear stress-induced cell migration. These results also do confirm that shear stress plays important roles in achieving and maintaining the stabilization of ECs.